Cochrane Abstracts
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Direct Thrombin Inhibitors Versus Vitamin K Antagonists or Low Molecular Weight Heparins for Prevention of Venous Thromboembolism Following Total Hip or Knee Replacement: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435189/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review. Accessed 24 January 2022.
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435189/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review. Accessed January 24, 2022.
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435189/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review
Direct Thrombin Inhibitors Versus Vitamin K Antagonists or Low Molecular Weight Heparins for Prevention of Venous Thromboembolism Following Total Hip or Knee Replacement: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2022 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435189/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
ID - 435189
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435189/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
